4//SEC Filing
FLESHER GREGORY J. 4
Accession 0000899243-20-009126
CIK 0001404281other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:31 PM ET
Size
5.7 KB
Accession
0000899243-20-009126
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-19+200,000→ 200,000 totalExercise: $0.26Exp: 2030-03-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 150,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705287
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:31 PM ET
- Size
- 5.7 KB